Printer Friendly

Symbicom obtains United States patent.

Symbicom AB (Umea, Sweden) has patented an expression system comprising a DNA sequence encoding a polypeptide which has a biological activity of human kappa -casein, the system comprising a 5'flanking sequence capable of mediating expression of said DNA sequence. In preferred embodiments the 5'-flanking sequence is from a milk protein gene of a mammal such as a casein gene or whey acidic protein (WAP) gene and the DNA sequence contains at least one intron sequence selected from the intron sequences presented in SEQ ID NO:30. The invention also relates to DNA sequences, replicable expression vectors and cells harboring said vectors, recombinant polypeptide e.g. in glycosylated form, and milk, infant formula or nutrient supplement comprising recombinant polypeptide. The invention further relates to a transgenic non-human mammal such as a mouse, rat, rabbit, goat, sheep, pig, lama, camel or bovine species whose germ cells and somatic cells contain a DNA sequence as defined above as a result of chromosomal incorporation into the non-human mammalian genome, or into the genome of an ancestor of said non-human mammal. (US 6232094)
COPYRIGHT 2001 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:#6232094
Publication:BIOTECH Patent News
Article Type:Brief Article
Geographic Code:1USA
Date:May 1, 2001
Previous Article:Emory University obtains United States patent.
Next Article:CompleGen obtains United States patent.

Related Articles
Isis obtains United States patent.
du Pont obtains United States patent.
ARCH obtains United States patent.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters